- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Marlborough Today
By the People, for the People
OFI Invest Asset Management Boosts Boston Scientific Holdings by Over 3,000%
The asset management firm significantly increased its stake in the medical device company during the fourth quarter.
Apr. 9, 2026 at 11:18am
Got story updates? Submit your updates here. ›
The heavy, tangible machinery of the medical device industry reflects the institutional wealth and financial security that drives investment in leading companies like Boston Scientific.Marlborough TodayOFI Invest Asset Management raised its holdings in Boston Scientific Corporation (NYSE:BSX) by 3,051.7% during the 4th quarter, according to the company's recent SEC filing. The firm now owns 334,242 shares of the medical equipment provider's stock, worth $31.87 million.
Why it matters
The large increase in OFI Invest's Boston Scientific holdings suggests the asset manager sees significant upside potential in the medical device company's stock. Boston Scientific is a major player in the cardiovascular, digestive, and chronic pain treatment markets, making it an important investment for institutional investors.
The details
OFI Invest Asset Management added 323,637 shares of Boston Scientific to its portfolio during the fourth quarter, bringing its total holdings to 334,242 shares. This represents a 3,051.7% increase compared to the previous quarter. Boston Scientific's stock has seen volatility in recent months, with the share price declining from over $100 to around $60 as of early 2026.
- OFI Invest Asset Management disclosed its increased Boston Scientific holdings in a 13F filing for the fourth quarter of 2025.
- The firm's Boston Scientific stake was valued at $31.87 million as of the end of 2025.
The players
OFI Invest Asset Management
An asset management firm that significantly increased its stake in Boston Scientific Corporation during the fourth quarter of 2025.
Boston Scientific Corporation
A global medical device company that develops, manufactures, and markets a broad portfolio of products used in less-invasive medical procedures.
The takeaway
OFI Invest Asset Management's large increase in Boston Scientific holdings suggests the firm sees strong growth potential in the medical device company's stock. This reflects the ongoing investor interest in Boston Scientific's diverse product portfolio and market position in key healthcare segments.
